Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Combined marker as well as application and detection kit thereof

A technology of markers and kits, applied in the field of analytical chemistry, can solve problems such as difficult diagnosis of retinopathy and difficulty in distinguishing complications of retinopathy, and achieve good diagnostic effect, good diagnostic effect, and good specificity

Active Publication Date: 2021-07-23
DALIAN INST OF CHEM PHYSICS CHINESE ACAD OF SCI
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The purpose of the present invention is to solve the clinical problem that the diagnosis of retinopathy in diabetic patients is difficult, especially the early retinopathy complications are difficult to distinguish, and propose a new serum metabolic marker that can be applied to the diagnosis of retinopathy in diabetic patients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Combined marker as well as application and detection kit thereof
  • Combined marker as well as application and detection kit thereof
  • Combined marker as well as application and detection kit thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] 1. Serum Sample Collection

[0037] Before the collection of serum samples, all volunteers included in the study signed the informed consent.

[0038] Serum samples were collected under the same conditions: 74 cases of diabetic patients without retinopathy as the control group and 234 cases of diabetic patients with retinopathy (including 66 cases of stage 1 mild diabetic retinopathy group and stage 2 moderate diabetic retinopathy group). 60 cases, 57 cases of stage 3 severe diabetic retinopathy group and 51 cases of stage 4 proliferative diabetic retinopathy group) were used as the disease group. After collection, the samples were stored in a -80°C refrigerator for future inspection.

[0039] 2. Analysis method

[0040] 2.1 Serum sample pretreatment

[0041]Thaw the sample at 4°C, take 50 μL of serum, add 200 μL of methanol extract containing internal standard compounds D4-succinic acid, D5-phenylalanine and tridecanoic acid (concentrations are 5 μg / mL), vortex for 3...

Embodiment 2

[0053] 1. Serum Sample Collection

[0054] Before the collection of serum samples, all volunteers included in the study signed the informed consent.

[0055] Serum samples were collected under the same conditions: 37 cases of diabetic patients without retinopathy as the control group and 116 cases of diabetic patients with retinopathy (including 33 cases of stage 1 mild diabetic retinopathy group and 2 cases of moderate diabetic retinopathy group). 30 cases, 28 cases of stage 3 severe diabetic retinopathy group and 25 cases of stage 4 proliferative diabetic retinopathy group) were used as the disease group. After collection, the samples were stored in a -80°C refrigerator for future inspection.

[0056] 2. Analysis method

[0057] With embodiment 1.

[0058] 3. Serum test results and auxiliary predictive analysis

[0059] The results of the verification set in Example 2 are basically consistent with the results of the discovery set in Example 1. In the diabetic retinopathy...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Sensitivityaaaaaaaaaa
Sensitivityaaaaaaaaaa
Sensitivityaaaaaaaaaa
Login to View More

Abstract

The invention relates to a novel application of small molecule metabolites ethanolamine, fumaric acid, hypotaurine and inositol in a serum sample as a combined marker in preparation of a kit for diagnosing whether a diabetic has retinopathy or not. The invention also relates to a kit for detecting retinopathy in diabetic patients, which is used for calculating the variable Prob value of the combined marker and judging the cut-off value (cut-off value) on the basis of a binary logistic regression equation by detecting the respective relative concentrations of the combined marker in the serum of the diabetic patients, and judging whether the diabetic suffers from retinal complications or not. The kit can realize high-sensitivity and high-efficiency detection of several small molecule metabolites involved in the invention, and has the characteristics of low detection cost and good repeatability. The method can be applied to auxiliary diagnosis of retinal complications in diabetic people, has a good effect in early diagnosis of diabetic retinopathy, and has a good application prospect.

Description

technical field [0001] The present invention relates to the application of a new small molecule combined marker in the diagnosis of diabetic retinopathy. It belongs to the fields of analytical chemistry, biochemistry and clinical medicine. Background technique [0002] Diabetes is one of the most common global metabolic diseases and its incidence has been increasing year by year. Diabetic retinopathy is one of the most common microvascular complications in diabetic patients, and it is also the main cause of visual impairment and blindness in adults [Reference 1: Nentwich M M, Ulbig M W. Diabetic retinopathy-ocular complications of diabetes mellitus[J]. World journal of diabetes, 2015, 6(3): 489.]. The presence and grade of diabetic retinopathy can be assessed clinically by performing a fundus examination after pupil dilation (mydriasis) to visualize the entire retina. Diabetic retinopathy can be divided into background retinal mutation stage and proliferative retinopathy ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N30/02G01N30/06G01N30/30G01N30/32G01N30/72G01N33/96
CPCG01N30/02G01N30/06G01N30/30G01N30/32G01N30/72G01N33/96G01N2030/324G01N2030/042
Inventor 许国旺王砚凤轩秋慧欧阳瑒赵欣捷赵春霞路鑫
Owner DALIAN INST OF CHEM PHYSICS CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com